Cure My Disease

Don't miss your cure!

 Log in / Sign up

Eye department study aims to map hidden patterns of nerve-related vision problems

NCT ID NCT07711886

Knowledge-focused Sponsor: The Royal Wolverhampton Hospitals NHS Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 17, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This study collects information from about 840 adults seen at a UK eye department who have neuro-ophthalmological conditions—problems where the eyes and brain interact. Researchers will analyze how often these conditions occur and how initial diagnoses compare with final ones. The goal is to improve service planning and help identify rare or emerging patterns earlier.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help eye departments better plan resources and spot rare neuro-ophthalmological conditions earlier.
What could go wrong
This is an observational study, so it does not test any treatment. Findings may not apply to other hospitals or regions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 840 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2027

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Consecutive patients seen at the Royal Wolverhampton NHS Trust's Eye Department who have a NO diagnosis and meet the eligibility criteria will be selected.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants aged ≥ 18 years. * Participants seen at the Royal Wolverhampton NHS Trust's Eye Department. * Participants with a diagnosis of NO. Exclusion Criteria: * Participants aged \< 18 years. * Participants who do not have a diagnosis of NO. * Participants who have opted out of their data being used for research (National Data Opt-out).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neuro-ophthalmological conditions are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neuro-ophthalmological conditions

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.